Transfusion Indication Threshold Reduction (TITRe2) randomized controlled trial in cardiac surgery: Statistical analysis plan

Trials

Volumn 16, Issue 1, 2015, Pages

  Pike, Katie ^a   Nash, Rachel L ^a   Murphy, Gavin J ^b   Reeves, Barnaby C ^a   Rogers, Chris A ^a  

^a UNIVERSITY OF BRISTOL   (United Kingdom)

^b UNIVERSITY OF LEICESTER   (United Kingdom)

Author keywords

Cardiac surgery; Red cell; Restrictive; Statistical analysis plan; Transfusion

Indexed keywords

HEMOGLOBIN;

ACUTE KIDNEY FAILURE; ADOLESCENT; ADULT; ARTICLE; ASSESSMENT OF HUMANS; BLOOD SAFETY; CEREBROVASCULAR ACCIDENT; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; EQ5D SINGLE SUMMARY INDEX SCORE; EQ5D VISUAL ANALOG SCALE SCORE; ERYTHROCYTE TRANSFUSION; HEART INFARCTION; HEART SURGERY; HEMOGLOBIN BLOOD LEVEL; HUMAN; INFECTION RISK; INTERMETHOD COMPARISON; INTESTINE INFARCTION; LENGTH OF STAY; MAJOR CLINICAL STUDY; MULTICENTER STUDY; POSTOPERATIVE INFECTION; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; SENSITIVITY ANALYSIS; SEPSIS; STATISTICAL ANALYSIS; SURGICAL INFECTION; SURGICAL MORTALITY; TREATMENT REFUSAL; VISUAL ANALOG SCALE; CLINICAL TRIAL; OUTCOME ASSESSMENT; PROTOCOL COMPLIANCE;

CARDIAC SURGICAL PROCEDURES; DATA INTERPRETATION, STATISTICAL; ERYTHROCYTE TRANSFUSION; GUIDELINE ADHERENCE; HUMANS; OUTCOME ASSESSMENT (HEALTH CARE); PROSPECTIVE STUDIES;

EID: 84924715011     PISSN: None     EISSN: 17456215     Source Type: Journal    
DOI: 10.1186/s13063-015-0564-x     Document Type: Article

References (20)

1. Murphy GJ, Reeves BC, Rogers CA, Rizvi SI, Culliford L, Angelini GD. Increased mortality, postoperative morbidity, and cost after red blood cell transfusion in patients having cardiac surgery. Circulation. 2007;116:2544-52.
2. Koch CG, Li L, Duncan AI, Mihaljevic T, Cosgrove DM, Loop FD, et al. Morbidity and mortality risk associated with red blood cell and blood-component transfusion in isolated coronary artery bypass grafting. Crit Care Med. 2006;34:1608-16.
3. Karkouti K, Wijeysundera DN, Yau TM, McCluskey SA, Chan CT, Wong PY, et al. Influence of erythrocyte transfusion on the risk of acute kidney injury after cardiac surgery differs in anemic and nonanemic patients. Anesthesiology. 2011;115:523-30.
4. Carson JL, Carless PA, Hebert PC. Transfusion thresholds and other strategies for guiding allogeneic red blood cell transfusion. Cochrane Database Syst Rev. 2012;4:CD002042.
5. Murphy MF, Murphy GJ, Gill R, Herbertson M, Allard S, Grant-Casey J. 2011 Audit of Blood Transfusion in Adult Cardiac Surgery. Birmingham: National Comparative Audit of Blood Transfusion; 2013.
6. Bennett-Guerrero E, Zhao Y, O'Brien SM, Ferguson Jr TB, Peterson ED, Gammie JS, et al. Variation in use of blood transfusion in coronary artery bypass graft surgery. JAMA. 2010;304:1568-75.
7. Brierley R, Pike K, Wordsworth S, Mumford A, Cohen A, Angelini GD, et al. A multi-centre randomised controlled trial of Transfusion Indication Threshold Reduction on transfusion rates, morbidity and healthcare resource use following cardiac surgery. Transfus Apher Sci. 2014;50:451-61.
8. International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human use: ICH harmonised tripartite guideline statistical principles for clinical trials E9. 1998. http://www.ich.org/fileadmin/Public_Web_Site/ICH_Products/Guidelines/Efficacy/E9/Step4/E9_Guideline.pdf.
9. EuroQol Group. EuroQol - a new facility for the measurement of health-related quality of life. Health Pol. 1990;16:119-208.
10. Schulz KF, Altman DG, Moher D, CONSORT Group. CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials. BMJ. 2010;340:c332.
11. Tooze JA, Grunwald GK, Jones RH. Analysis of repeated measures data with clumping at zero. Stat Methods Med Res. 2002;11:341-55.
12. Carpenter JR, Kenward MG. Missing data in clinical trials - a practical guide. Birmingham: National Health Service Coordinating Centre for Research Methodology, Publication RM03/JH17/MK. 2007. http://missingdata.lshtm.ac.uk/downloads/rm04_jh17_mk.pdf .
13. Wilson AP, Treasure T, Sturridge MF, Gruneberg RN. A scoring method (ASEPSIS) for postoperative wound infections for use in clinical trials of antibiotic prophylaxis. Lancet. 1986;1:311-3.
14. Gibbons C, Bruce J, Carpenter J, Wilson AP, Wilson J, Pearson A, et al. Identification of risk factors by systematic review and development of risk-adjusted models for surgical site infection. Health Technol Assess. 2011;15(30):1-156.
15. Assmann SF, Pocock SJ, Enos LE, Kasten LE. Subgroup analysis and other (mis)uses of baseline data in clinical trials. Lancet. 2000;355:1064-9.
16. Mehta RL, Kellum JA, Shah SV, Molitoris BA, Ronco C, Warnock DG, et al. Acute kidney injury network: report of an initiative to improve outcomes in acute kidney injury. Critical Care. 2007;11:R31.
17. Medical Dictionary for Regulatory Activities. http://www.meddra.org/ .
18. Greenland S. An introduction to instrumental variables for epidemiologists. Int J Epidemiol. 2000;29(4):722-9.
19. Essebag V, Platt RW, Abrahamowicz M, Pilote L. Comparison of nested case-control and survival analysis methodologies for analysis of time-dependent exposure. BMC Med Res Methodol. 2005;5:5.
20. Rasmussen K, Schroll J, Gøtzsche, PC, Lundh, A. Underreporting of conflicts of interest among trialists: a cross-sectional study. 2013. http://www.peerreviewcongress.org/2013/Plenary-Session-Abstracts-9-9.pdf